Thanh bên bài viết

PDF
Ngày xuất bản: 20/10/2023
Ngày xuất bản Online: 20/10/2023
Số lượt xem tóm tắt: 79
Số lượt xem PDF: 54
DOI: https://doi.org/10.58490/ctump.2023i6.2064
Số xuất bản
Số 6 (2023): SỐ TIẾNG ANH
Chuyên mục
Bài báo
Trích dẫn bài báo
Le, T. C. T., Lam, N. A., Le, N. M. N., Nguyen, H. T., Nguyen, T. T. T., Nguyen, T. N. T., Ly, H. V. H., Le, N. C., & Dang, D. K. (2023). THE ANTIDEPRESSANT USAGE RATE AND TREATMENT OUTCOMES FOR OUTPATIENTS WITH DEPRESSION AT CAN THO PSYCHIATRIC HOSPITAL FROM 2022 TO 2023. Tạp chí Y Dược học Cần Thơ, 6, 144-149. https://doi.org/10.58490/ctump.2023i6.2064

THE ANTIDEPRESSANT USAGE RATE AND TREATMENT OUTCOMES FOR OUTPATIENTS WITH DEPRESSION AT CAN THO PSYCHIATRIC HOSPITAL FROM 2022 TO 2023

Le Thi Cam Tu1, Lam Nhut Anh1, Le Nguyen Minh Ngoc1, Nguyen Huu Truc1, Nguyen Thi Thanh Tam1, Nguyen Thi Nhu Trang1, Ly Huynh Vinh Hung1, Le Ngoc Cua2, Dang Duy Khanh1,
1 Can Tho University of Medicine and Pharmacy, Vietnam
2 University of Walailak, Thailand

Nội dung chính của bài viết

Tóm tắt

Background: Depression is a prevalent condition that affects individuals globally. It can cause significant emotional pain and hinder one's ability to perform well in various settings such as work, school, and home. Diagnosing and treating depression can be challenging due to limited resources, a shortage of trained healthcare providers, and the social stigma often attached to mental disorders. Objectives: The objective of this study is to identify the types and quantities of antidepressant drugs prescribed and received, as well as to assess the outcomes of treatment for depressed patients who received outpatient care at Can Tho Psychiatric Hospital between 2022 and 2023. Materials and methods: A descriptive cross-sectional study of 255 patients aged 18 and older was conducted at Can Tho Psychiatric Hospital in 2022-2023. Data were analyzed using SPSS 20. Results: Most patients (39.6%) were aged 18-29, and 76.1% were female. Patients had varying levels of depression, with the majority having moderate to severe depression. The most commonly prescribed first-line antidepressants were fluoxetine (35.3%) and sertraline (50.6%), both of which are SSRIs (Selective serotonin reuptake inhibitors). After 2 and 6 weeks of treatment, patients' depression levels significantly improved (p<0.001). Remission rates increased from 29.3% (±12.4%) after 2 weeks to 69.9% (±17.8%) after 6 weeks of treatment, with a statistically significant difference (p<0.001). While only the sleep disorder symptom group showed improvement after 2 weeks, all symptoms showed a high remission rate after 6 weeks of treatment. Improvement rates after 2 and 6 weeks were 8.6% and 85.9%, respectively. Conclusions: SSRIs are commonly prescribed as the first-line treatment for outpatients experiencing depression. Sertraline is the most frequently prescribed medication. Depression is prevalent in young women between 18 and 29, many of whom experience severe symptoms. Treatment can greatly improve all symptoms in six weeks, with sleep disturbances showing the most improvement. It is important to seek help promptly and recognize symptoms to achieve the best result.

Chi tiết bài viết

Từ khóa

antidepression, Can Tho, SSRI, HAMD-17

Tài liệu tham khảo

1. WHO. WHO highlights urgent need to transform mental health and mental health care. 2022.https://www.who.int/news/item/17-06-2022-who-highlights-urgent-need-to-transformmental-health-and-mental-health-care.
2. WHO. Mental health in Viet Nam. 2023. https://www.who.int/vietnam/vi/health-topics/mentalhealth/mental-health
3. WHO. Mental health action plan for WHO South-East Asia Region 2023–2030. 2023. https://www.who.int/publications/i/item/9789290210689
4. Ha Thanh Tu. Survey on understanding of depression among relatives and drug treatment adherence of patients with depression. University of Medicine and Pharmacy, Ho Chi Minh City. 2019.
5. Tran Thi Thuy Nga, Doan Thi Phuong Thuy, Tran Le Thien Nhat, Nguyen Thi Thuy Trang, Analysing antidepressant use in depression outpatients at Da Nang Psychiatric hospital. Hue Journal of medicine and pharmacy. 2020. 10(3). 50-56. DOI: 10.34071/jmp.2020.3.7.
6. Nguyen Van Thong, Thieu Quang Hung, Tran Thien Thang. The clinical feature and treatment results of depression on outpatient at Cantho Psychiatric hospital 2014-2015. Can Tho Journal of medicine and pharmacy. 2018. 15. 178-183.
7. Nguyen Thanh Hai, Nguyen Huong Ly, Nguyen Van Tuan, Nguyen Xuan Bach. Current Status of Drug Use in Patients with Depression at the National Institute of Mental Health - Bach Mai Hospital. Vietnam national university journal of science. 2018. 34(1). 114-119. http://doi.org/10.25073/2588-1132/vnumps.4075
8. Ministry of Health. Guidelines for the Diagnosis and Treatment of Common Mental Disorders, No.2058/QĐ-BYT dated May 14th. 2020. Ha Noi,
9. Dionisie, V., Filip, G.A., Manea, M.C. et al. The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies. Inflammopharmacol. 2021. 29. 75–90. https://doi.org/10.1007/s10787-020-00777-5.
10. Susannah E. M., Liliana P.C., Sophie L.C. G., Philip J. C., Argyris. S,. The knows and unknows of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanism of action. Active ingredients for addressing youth anxiety and depression. 8(9). 2021. 824-835. https://doi.org/10.1016/S2215-0366(21)00154-1.